Dechra Pharmaceuticals shares sink as wholesalers de-stock

Dechra Pharmaceuticals shares were down heavily on Monday after the specialist veterinary pharmaceutical group said wholesalers were going through a period of de-stocking which would hit profits this year.

De-stocking has caused volatile trading conditions for Dechra, who now see operating profits below the £186m guided for in February. Dechra noted stock management trends in the US were also evident in the UK.

Dechra made concerning comments about the health of trade in the rest of Europe: “The market appears to be slowing in response to the changing macro-economic environment and country specific dynamics.”

Despite wholesaler activity causing challenging conditions for Dechra between January and April, the company said end demand from veterinary practitioners remained strong.

Dechra Pharmaceuticals shares were trading down 9.8% at the time of writing.

Brokers are targeting 250% upside in this London-listed platinum group metals (PGMs) producer

Plans to expand platinum production could mean this London-listed company is soon one of the world's top ten producers. In addition to PGMs, the company mines significant levels of chrome concentrate.
After their half-year results were released, equity analysts issued a note reiterating a price target 250% higher than the company's current share price.
Underpinning the analysts' price target, Johnson Matthey's recent PGM Market Report forecasts growing demand for the PGMs produced by this miner.
The share price has declined since a peak in early 2022, and the stock now trades at a PE Ratio o...

Aquis weekly movers: Asimilar to concentrate on Aquis quotation

Asimilar Group (LON: ASLR) is leaving AIM on 26 May and retaining the Aquis quotation. The Aquis share price rose by one-quarter to 0.75p. Chirs Akers increased his stake in the technology investment company from 10.3% to 11.1%.

Equipmake Holdings (LON: EQIP) has signed a licensing agreement with Sona Comstar, covering some of its range of drive motors and powertrains for their use in electric cars, buses and other vehicles in India and other south Asian countries. The two companies may jointly address other markets. Equipmake receives a one-off licence fee plus royalties. Production will commence in 2025. The share price increased 5.56% to 9.5p.

DXS International (LON: DXSP) says full year revenues will be slightly higher at £3.3m and there was a very small profit after tax. That is likely to be after a research and development tax credit, so there could be a pre-tax loss. Management believes that revenues can be increased substantially in the medium-term. Cash has been raised to market the newly developed software products. DXS International has raised £500,000 at 4p a share, while £131,000 of debt has been swapped for shares at the same price. The share price slumped 17.6% to 3.5p.

Technology investment company SuperSeed Capital (LON: WWW) had net assets of 101p a share at the end of 2022. Last year’s flotation enabled the company says there are opportunities in the software sector. The company’s fund performed well, but there are unlikely to be significant increases in investment valuations this year. However, revenues from the existing portfolio are expected to double. The share price declined 12.1% to 72.5p.

Macaulay Capital (LON: MCAP) had net assets of £1.44m, including cash of £1.19m, at the end of 2022. There was a cash outflow of £428,000. The first investment was in cakes and cereal bars maker Devonvale. There was a subsequent investment in precision engineer Camloc Motion Control. The initial investment of £700,000 will be reduced to £200,000 by selling to third parties. There are other investment opportunities. The share price fell 11.8% to 22.5p.

Ananda Developments (LON: ANA) has filed four patent applications. The cannabinoid-based medicines developer has appointed SP Angel as corporate adviser. The share price slipped 5.6% to 0.59p.

Coinsilium Group Ltd (LON: COIN) has completed the £116,500 cash and shares acquisition of the Tokenomi Web3 advisory service business, which has seven blockchain clients and a pipeline of ten more. The share price declined 3.57% to 1.35p.

Guanajuato Silver (LON: GSVR) reported drilling results from San Ignacio and Topia. Drilling at the former has shown an extension of the existing high grade area. There are also narrow veins with high grades at the Topia mine. The share price fell 3.08% to 31.5p.

AIM weekly movers: Egdon Resources agrees bid

3

Egdon Resources (LON: EDR) is recommending a 4.5p a share cash bid from Petrichor Partners. This values the UK-focused oil and gas company at £26.6m. The share price jumped 89.1% to 4.35p, which is the highest it has been for six months, making it the largest riser on the week. Petrichor is owned by HEYCO, which provides services and capital to oil and gas projects in the US and Europe.

Some better news for IOG (LON: IOG). The control event at the Blythe H2 well in the North Sea has been successfully isolated. The first gas from this well should be produced by the end of June. The share price rebounded 35.4% to 7.04p – the highest price since February.

Xeros Technology Group (LON: XSG) has signed a ten-year technology licence and distribution agreement with KRM Tekstil Boya, which will distribute denim processing equipment. Denim processing uses lots of water and energy and this will be reduced by this equipment. Xeros will receive a royalty on each machine sold and will supply XOrbs for the machine. The launch will be later this year. The share price is 25.8% higher at 3.9p.

ImmuPharma (LON: IMM) says that there was positive feedback from a consultation with the US FDA. This will help with the design of the phase 2/3 clinical study of the P140 treatment in chronic idiopathic demyelinating polyneuropathy. The trial could begin in the second half of 2023 and a Lupus trial could also start later in the year. The share price recovered 23.5% to 3.21p.

==========

Fallers

Mirada (LON: MIRA) has set out plans to cancel its AIM quotations. The IPTV technology provider has been quoted for more than two decades, but a large shareholder with a 87.2% stake has limited liquidity and investor interest in the shares. The major lender to Mirada is also related to the main shareholder. This means that the cancellation will happen, and the shares will then be traded by JP Jenkins. That should save costs of $470,000/year. The share price dived 84.2% to 3p. This is the lowest the share price has ever fallen to.

Antibody discovery company Fusion Antibodies (LON: FAB) has raised £1.56m at 5p a share and a REX retail offer could raise more. The offer closes on 22 May. The share price slumped 79.3% to 7.75p. The cash and cost saving measures will provide enough funds to enable Fusion Antibodies to offer its Integrated Therapeutic Antibody Service, as well as further developing the OptiMAL therapeutic antibody discovery platform.

Tower Resources (LON: TRP) is raising £2.3m at 0.05p a share. This will fund the preparation of drilling of the NJOM-3 well in Cameroon. It will also fund work on interests in Namibia and South Africa. The share price slumped 57.1% to 0.0515p – a new all-time low.

Purplebricks (LON: PURP) is selling its business and assets to Strike Ltd for £1 and cancelling its AIM quotation. That should leave £5.5m in cash in Purplebricks. The cash remaining after costs, which could be £2m, will be distributed to shareholders, but that won’t happen until early next year. At 0.77p, down 48.1%, Purplebricks is valued at £2.4m.

FTSE 100 rallies as sentiment improves

The FTSE 100 was gaining momentum on Friday as the index benefitted from improving sentiment in global equities.

The FTSE 100 was 0.55% higher at the time of writing while the S&P crept 0.2% higher after a strong session overnight.

Global equities began a move to the upside yesterday as interest rate markets priced in a pause in US rate hikes.

“The markets continue in a holding pattern with the FTSE 100 stuck in a tight range between 7,700 and 7,800 as investors await key economic data which could set equities on a path up or down,” said AJ Bell investment director Russ Mould.

“Today was a positive day for UK stocks despite warnings overnight from a Federal Reserve official that the end to the rate-hiking cycle might not come as soon as Wall Street hopes. 

“Investors will be hunting for clues on the direction of monetary policy from Fed chair Jerome Powell when he addresses a conference in Washington later on Friday.”

The fallout from Powell’s speech may have ramifications for the start of European trade on Monday.

FTSE 100 movers

The top movers were driven by mean reversion on Friday as stocks with sharp swings yesterday moved to cover a degree of their fluctuations.

BT was the FTSE 100’s top riser a day after sinking following the release of their final results. BT shares were 3% higher at the of writing.

Conversely, JD Sports, down over 6%, was the top faller after gaining on the back of results yesterday.

However, Burberry suffered another day of selling after warning they would face unfavourable economic conditions for the rest of the year. Burberry was another 3.8% weaker at the time of writing.

Capturing India’s economic expansion with India Capital Growth Fund

The UK Investor Magazine Podcast with Gaurav Narain, Co-Head Equities at Ocean Dial Asset Management, for a deep dive into Indian growth equities.

Find out more about the India Capital Growth Fund.

Gaurav Narain manages the India Capital Growth Fund (LON:IGC), a growth-focused India equity investment trust.

The trust has rallied 228% over the past three years. We explore the main drivers behind the performance.

Gaurav provides a comprehensive overview of India’s economy and the favourable environment for growth equities. Attention is paid to how India is benefitting from the move away from China.

AIM movers: IQE share price recovers and Fusion Antibodies heavily discounted fundraising

0

IQE (LON: IQE) has bounced back following the fundraising earlier in the week. It raised £30m at 20p a share and a retail offer brought in a further £1.1m. The share price recovered 16% to 24.075p.

A positive trading statement from legal services provider Knights Group Holdings (LON: KGH) has helped the share price recover 7.88% to 91.7p. Full year revenues will be 13% ahead at £142m and pre-tax profit will be nearly one-fifth higher at £21.5m. Net debt is estimated to be £29m, well within the bank facilities. That figure is before the most recent acquisitions.

Asiamet Resources Ltd (LON: ARS) chief executive Darryn McClelland bought 5.5 million shares at 1p each. The share price rose 7.69% to 1.05p.

GeneDrive (LON: GDR) shares soared above 24p earlier in the day, but they have fallen back to 21.75p, which is 6.1% higher. The National Institute for Health & Care Executive has recommended GeneDrive’s CYP2C19 molecular genetic test for stroke patients. The test should get UKCA marking for the test before the final guidance report in October.

Antibody discovery company Fusion Antibodies (LON: FAB) has raised £1.56m at 5p a share and a REX retail offer could raise more. The share price slumped 74.6% to 8p. The cash and cost saving measures will provide enough funds to enable Fusion Antibodies to offer its Integrated Therapeutic Antibody Service, as well as further developing the OptiMAL therapeutic antibody discovery platform.

Mirada (LON: MIRA) shares continue to fall after it set out plans to cancel its AIM quotation. The latest fall of 53.9% to 3p, means that the share price has fallen by more than four-fifths this week.

Sustainable fuels developer Velocys (LON: VLS) intends to raise £6m in a placing at 2.5p a share and a retail offer could raise up to £500,000. An open offer could raise up to £2m more. The share price declined 27.5% to 2.445p. Carbon Direct Capital is subscribing for a minimum of £12m of convertible loan stock – the conversion price is 2.5p or it could be lower if more shares are issued at a lower price. The structure of the convertible incentivises a US listing within 21 months. The cash raised will be invested in fuels projects in the UK and US and the commissioning of an Ohio manufacturing facility.  

Unbound Group (LON: UBG) has commenced a strategic review and formal sales process following the failure to secure a cash injection from Marwyn. The focus will be Hotter Shoes in the UK with overseas consumer sales being temporarily ended. There is a danger of a shortage of cash in the autumn. The share price fell 15.4% to 2.75p.

BT shares: AJ Bell on why the telecoms group could be in big trouble

BT shares have provided investors with terrible returns in recent years. Shares are down around 30% over the past five years, and numerous initiatives to win investors over have failed.
The business is stricken by a massive pension liability, and it limits its ability to invest meaningfully. It also makes it an unattractive takeover target because any bidder would assume the pension liability.
BT has struggled to grow in terms of revenue. In fact, it's shrunk. Consistently.
Sales have dropped in the last five years compared to the previous year. In 2019, BT recorded sales of £23.4bn. This has...

MicroSalt makes another step towards AIM IPO with celebrity chef partnership

Although we are yet to learn the exact date of Tekcapital’s MicroSalt IPO, the recent news flow would suggest things are beginning to heat up.

Today, Tekcapital announced MicroSalt have brought in Rick Stein’s son Jack as a brand ambassador. Such a significant move signals the company is positioning itself towards the UK market.

“I am absolutely delighted to be working with MicroSalt to show how a true low-sodium salt can produce the same taste while providing significant benefits to health. As a chef, salt is the most important ingredient, and this product is game changing, said Jack Stein, Chef Director for Rick Stein.

Mr Stein will help develop MicroSalt’s culinary audience and educate consumers about the health benefits of lower sodium consumption.

Today’s announcement follows yesterday’s news MicroSalt had secured distribution in an additional 400 US stores.

MicroSalt has recorded many successes with distribution agreements across 1000s of US stores, including Kroger – one of the United States’ largest supermarkets.

The move to align themselves with a prominent UK chef highlights intentions to raise their profile in the UK, not only for a possible product launch but for a listing on AIM.

MicroSalt appointed Zeus Capital as their NOMAD last year in preparation for an AIM IPO. Tekcapital previously said they were targeting an IPO in 2023, but with the current state of capital markets and near-constant commercial updates, it is understandable why MicroSalt are biding their time.

FTSE 100 edges higher as global equities rally

The FTSE 100 edged higher on Thursday in a broad global equity rally which saw European and US equities gain.

Downbeat economic data has been responsible for stock declines so far this week. However, the deterioration in US data has caused a shift in market expectations of interest rate trajectories.

Markets now predict the Federal Reserve will pause interest rate hikes in the coming months. On Thursday, the prospect borrowing costs will not increase again in the short term helped support sentiment and risk assets.

The FTSE 100 gained 0.2% on Thursday, while the S&P 500 had jumped 0.4% at the time of writing.

Despite improving sentiment on Thursday, analysts cautioned the looming debt ceiling could bring today’s positivity to an abrupt end.

“Despite this positive sentiment, there remains a large elephant in the room. Joe Biden is dangerously close to the 1 June deadline to reach an agreement on raising the US debt limit, otherwise the US government will default on its bills,” said Russ Mould, investment director at AJ Bell.

“That could cause all kinds of problems with federal workers and to the US economy and likely cause a global stock market correction.”

FTSE 100 movers

A day after saying they were targeting record £1 billion earnings this year, JD Sports received broker upgrades sending shares over 5% higher. JP Morgan has hiked their price target to 215p from 210p.

JD Sports shares were 5.4% higher at 172p at the time of writing.

BT

BT shares sank on Thursday after the telecoms group announced full-year results. Revenue was down 1%, and operating profit slipped 12%.

The group is taking steps to cut costs by slashing 55,000 jobs, but concerns about cash generation sent the stock down by around 5%.

“Headlines will no doubt focus on the job cuts, with up to 55,000 to come over the next decade as BT looks to find more ways to cut costs despite a cost-cutting plan already delivering £2.1bn in savings. It’s drastic, but it’s not overly surprising given the mounting costs and slim margins in the wider business,” said

“Once the Openreach and 5G networks are built out the strategy shifts to monetising the infrastructure that’s in place and leveraging new technologies to do that. Progress on both is looking promising, BT’s 5G now covers 68% of the population and Openreach is on track to reach 25m premises by 2026. 

“Challenges are looming, though, not least a pension review in the coming months that’s likely to result in a write-down, which will add to the burdens on cash, whether in the form of increased payments now or an extension to the deficit recovery timeframe.”

Burberry

Burberry shares were over 5% weaker following the release of full-year results. Burberry saw improvement last year as China reponed, but kept guidance the same and highlighted poor macroeconomic conditions.

Investors took the comments as a signal to book profits in the company after a bumper run in the stock.